ROIV Dividend: Roivant Sciences Ltd Yield Insights

Breakdown	TTM	03/31/2025	03/31/2024	03/31/2023	03/31/2022	03/31/2021
Revenue	20	29	32	61	55	23
Revenue Growth (YoY)	-74%	-9%	-48%	11%	139%	-66%
Cost of Revenue	0	0	1	13	8	2
Gross Profit	19	28	31	48	46	21
Selling, General & Admin	565	591	416	600	775	259
Research & Development	604	550	439	622	622	832
Operating Expenses	1,170	1,141	856	1,223	1,397	1,092
Other Non Operating Income (Expenses)	-29	5	-60	-62	6	-33
Pretax Income	-865	-681	4,567	-1,224	-923	-898
Income Tax Expense	35	48	21	5	0	1
Net Income	-373	-171	4,348	-1,009	-845	-809
Net Income Growth	-108%	-104%	-531%	19%	4%	-172%
Shares Outstanding (Diluted)	680.94	725.39	831.04	712.79	669.75	684.79
Shares Change (YoY)	-7%	-13%	17%	6%	-2%	0%
EPS (Diluted)	-0.54	-0.23	5.23	-1.41	-1.26	-1.18
EPS Growth	-108%	-104%	-471%	12%	7%	-172%
Free Cash Flow	-784	-844	-766	-856	-695	-557
Free Cash Flow Per Share	-1.15	-1.16	-0.92	-1.2	-1.03	-0.81
Gross Margin	95%	96.55%	96.87%	78.68%	83.63%	91.3%
Operating Margin	-5,750%	-3,837.93%	-2,575%	-1,926.22%	-2,456.36%	-4,652.17%
Profit Margin	-1,864.99%	-589.65%	13,587.5%	-1,654.09%	-1,536.36%	-3,517.39%
Free Cash Flow Margin	-3,920%	-2,910.34%	-2,393.75%	-1,403.27%	-1,263.63%	-2,421.73%
EBITDA	-1,144	-1,099	-802	-1,157	--	--
EBITDA Margin	-5,720%	-3,789.65%	-2,506.25%	-1,896.72%	--	--
D&A For EBITDA	6	14	22	18	--	--
EBIT	-1,150	-1,113	-824	-1,175	-1,351	-1,070
EBIT Margin	-5,750%	-3,837.93%	-2,575%	-1,926.22%	-2,456.36%	-4,652.17%
Effective Tax Rate	-4.04%	-7.04%	0.45%	-0.4%	0%	-0.11%

Roivant Sciences Ltd (ROIV) Price